Year |
Citation |
Score |
2018 |
Zhao H, Mitra N, Kanetsky PA, Nathanson KL, Rebbeck TR. A practical approach to adjusting for population stratification in genome-wide association studies: principal components and propensity scores (PCAPS). Statistical Applications in Genetics and Molecular Biology. PMID 30507552 DOI: 10.1515/Sagmb-2017-0054 |
0.558 |
|
2015 |
Alkhouli M, Zack CJ, Zhao H, Shafi I, Bashir R. Comparative outcomes of catheter-directed thrombolysis plus anticoagulation versus anticoagulation alone in the treatment of inferior vena caval thrombosis. Circulation. Cardiovascular Interventions. 8: e001882. PMID 25663321 DOI: 10.1161/Circinterventions.114.001882 |
0.311 |
|
2014 |
Bashir R, Zack CJ, Zhao H, Comerota AJ, Bove AA. Comparative outcomes of catheter-directed thrombolysis plus anticoagulation vs anticoagulation alone to treat lower-extremity proximal deep vein thrombosis. Jama Internal Medicine. 174: 1494-501. PMID 25047081 DOI: 10.1001/Jamainternmed.2014.3415 |
0.302 |
|
2012 |
Zhao H, Rebbeck TR, Mitra N. Analyzing genetic association studies with an extended propensity score approach. Statistical Applications in Genetics and Molecular Biology. 11. PMID 23104843 DOI: 10.1515/1544-6115.1790 |
0.563 |
|
2012 |
Sepe DM, McWilliams T, Chen J, Kershenbaum A, Zhao H, La M, Devidas M, Lange B, Rebbeck TR, Aplenc R. Germline genetic variation and treatment response on CCG-1891. Pediatric Blood & Cancer. 58: 695-700. PMID 21618417 DOI: 10.1182/Blood.V116.21.2711.2711 |
0.573 |
|
2012 |
Carlisle AJ, Pawal B, Carlisle R, Jagannathan J, Martinez D, Zhao H, Wang Q, Cole K, Lyttle CA, Nguyen N, Maris JM. Abstract 5566: Elevated CXCR4 expression is clinically correlated with advanced stage neuroblastoma: examination of its role as a possible therapeutic target Cancer Research. 72: 5566-5566. DOI: 10.1158/1538-7445.Am2012-5566 |
0.3 |
|
2009 |
Zhao H, Rebbeck TR, Mitra N. A propensity score approach to correction for bias due to population stratification using genetic and non-genetic factors. Genetic Epidemiology. 33: 679-90. PMID 19353632 DOI: 10.1002/Gepi.20419 |
0.552 |
|
2007 |
Adamson PC, Zhao H, Sievert A, Troxel A, Aplenc R. A simulation study to define the number of patients necessary to meet primary pharmacokinetic (pk) aims of phase I oncology trials Journal of Clinical Oncology. 25: 2579-2579. DOI: 10.1200/Jco.2007.25.18_Suppl.2579 |
0.466 |
|
2005 |
Aplenc R, Thompson J, Han P, La M, Zhao H, Lange B, Rebbeck T. Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia. Cancer Research. 65: 2482-7. PMID 15781665 DOI: 10.1158/0008-5472.Can-04-2606 |
0.581 |
|
2003 |
Aplenc R, Zhao H, Rebbeck TR, Propert KJ. Group sequential methods and sample size savings in biomarker-disease association studies. Genetics. 163: 1215-9. PMID 12663557 |
0.519 |
|
Show low-probability matches. |